Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long Non-Coding RNA PVT1 Regulates the Resistance of the Breast Cancer Cell Line MDA-MB-231 to Doxorubicin via Nrf2
Ying Luo, Wei Zhang, Liang Xu, et al.
Technology in Cancer Research & Treatment (2020) Vol. 19
Open Access | Times Cited: 19

Showing 19 citing articles:

Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC
Paola Ferrari, Cristian Scatena, Matteo Ghilli, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1665-1665
Open Access | Times Cited: 114
Long non-coding RNA mediated drug resistance in breast cancer
Deepshikha Singh, Yehuda G. Assaraf, Rajesh N. Gacche
Drug Resistance Updates (2022) Vol. 63, pp. 100851-100851
Closed Access | Times Cited: 96
Exploring extracellular RNA as drivers of chemotherapy resistance in cancer
Yumna Khan, Md Sadique Hussain, Prasanna Srinivasan Ramalingam, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access | Times Cited: 2
lncRNA PVT1: a novel oncogene in multiple cancers
Ruiming Li, Xia Wang, Chunming Zhu, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 50
Targeting epigenetic and post-translational modifications of NRF2: key regulatory factors in disease treatment
Xinyi Yang, Yingchao Liu, Jie Cao, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Long non-coding RNA (lncRNA) PVT1 in drug resistance of cancers; focus on pathological mechanisms
Saade Abdalkareem Jasim, Ali A. Majeed, Herlina Uinarni, et al.
Pathology - Research and Practice (2024), pp. 155119-155119
Closed Access | Times Cited: 5
Allicin Overcomes Doxorubicin Resistance of Breast Cancer Cells by Targeting the Nrf2 Pathway
Guojian Shi, Xiaohua Li, Weiping Wang, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 2, pp. 659-667
Closed Access | Times Cited: 4
Development of a tertiary lymphoid structure-based prognostic model for breast cancer: integrating single-cell sequencing and machine learning to enhance patient outcomes
Xiaonan Zhang, Li Li, Xiaoyu Shi, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Regulation of immune-mediated chemoresistance in cancer by lncRNAs: an in-depth review of signaling pathways
Saade Abdalkareem Jasim, Farag M. A. Altalbawy, Subasini Uthirapathy, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Insights into the involvement of long non-coding RNAs in doxorubicin resistance of cancer
Haibo Zhang, Yang Hu, Jun‐Li Deng, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Targeted therapy approaches for epithelial-mesenchymal transition in triple negative breast cancer
Mazharul Haque, Ritis Kumar Shyanti, Manoj Kumar Mishra
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Exploiting Long Non-Coding RNAs and Circular RNAs as Pharmacological Targets in Triple-Negative Breast Cancer Treatment
Alina Catalina Palcau, Renata Brandi, Nikolay Mehterov, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4181-4181
Open Access | Times Cited: 7
Potential Medical Use of Fullerenols After Two Decades of Oncology Research
Rade Injac
Technology in Cancer Research & Treatment (2023) Vol. 22
Open Access | Times Cited: 7
Decoding the Oncogenic Signals from the Long Non-Coding RNAs
Revathy Nadhan, Danny N. Dhanasekaran
Onco (2021) Vol. 1, Iss. 2, pp. 176-206
Open Access | Times Cited: 15
Long non-coding RNA PVT1: A promising chemotherapy and radiotherapy sensitizer
Weiping Yao, Shuang Li, Ruiqi Liu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
LGR4 attenuates MGP expression and suppresses EGFR activation-induced triple-negative breast cancer metastasis
Q. Li, Yankun Gao, Zitian Huo, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 7, pp. 3419-3432
Open Access | Times Cited: 1
Noncoding RNAs Controlling Oxidative Stress in Cancer
Paul Holvoet
Cancers (2023) Vol. 15, Iss. 4, pp. 1155-1155
Open Access | Times Cited: 3
Advances in the Understanding of the Pathogenesis of Triple‐Negative Breast Cancer
Yiwei Liu, Yuhan Zou, Yangli Ye, et al.
Cancer Medicine (2024) Vol. 13, Iss. 22
Open Access
Knockdown of PVT1 Exerts Neuroprotective Effects against Ischemic Stroke Injury through Regulation of miR-214/Gpx1 Axis
Xiaozhou Liu, Tian Wang, Ping Jing, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 2
Page 1

Scroll to top